Reposted by Giampaolo TrivellinENEA Young Researchers Committee (EYRC) @eyrc.bsky.social · 21/01/2026Following our latest Neuroendocrinology Watch by EYRC on LinkedIn: DNA methylation profiling identifies high-risk SF1+ nonfunctioning PitNETs and predicts post-surgical regrowth. Precision medicine is coming to PitNETs. 011
Reposted by Giampaolo TrivellinENEA Young Researchers Committee (EYRC) @eyrc.bsky.social · 19/02/2026On behalf of the EYRC, Dr Mario Detomas interviewed Professor Mirjam Christ-Crain during the 9th ENEA Workshop held in Marseille, France, in December 2025. Follow us on Linkedin for the full video! 011
Reposted by Giampaolo TrivellinENEA Young Researchers Committee (EYRC) @eyrc.bsky.social · 13/03/2026🧠 New EYRC Literature Review out now! This time: a large RCT on targeted correction of chronic hyponatremia. Read the summary on LinkedIn 👇 011
Reposted by Giampaolo TrivellinENEA Young Researchers Committee (EYRC) @eyrc.bsky.social · 31/03/2026🚨 Neuroendocrinology Watch by EYRC! This week, we highlight a novel retrospective cohort study exploring CXCR4-targeted imaging in Cushing’s disease. For more information => Visit our LinkedIn page 011
Reposted by Giampaolo TrivellinENEA Young Researchers Committee (EYRC) @eyrc.bsky.social · 04/04/2026🚨 Neuroendocrinology Watch by EYRC! This week, we highlight a single-nucleus multi-omics study of non-functioning pituitary adenomas (NFPAs), exploring their epigenetic landscape, gene regulatory modules, and tumor microenvironment. => Visit our Linkedin page for more details 021
Reposted by Giampaolo TrivellinENEA Young Researchers Committee (EYRC) @eyrc.bsky.social · 17/04/2026🧠 Neuroendocrinology Watch by EYRC! Immune checkpoint inhibitors (ICIs) have transformed oncology — but they come with a price: immune-related endocrine adverse events, including pituitary dysfunction. => More on LinkedIn 011
Giampaolo Trivellin @gp83.bsky.social · 08/01/2026As a current member of the EJE Rising Stars Reviewer Board, I can highly recommend this mentorship programme! Applications are now open for the 2026–2028 cohort. Don’t miss this opportunity! ⏰ Deadline: 16 Jan 2026 #Endocrinology #AcademicPublishing #AcademicCareers #PeerReview #Mentorship #ECR 010
Reposted by Giampaolo TrivellinESE Young Endocrinologists and Scientists (EYES) @ese-eyes.bsky.social · 27/09/2025What a kickoff! 🎉 Day 1️⃣ of #EYES2025 in Milan was buzzing with energy, ideas, and networking. 🌟 Inspiring plenary lecture by Prof. Stratakis 🤝 Lively joint session with EYRC 🧪 Brilliant talks & posters from our ECIs Day 2️⃣ — we’re ready! 🌱 @esendocrinology.bsky.social @ksaravinovska.bsky.social 051
Reposted by Giampaolo TrivellinENEA Young Researchers Committee (EYRC) @eyrc.bsky.social · 22/08/2025Dont miss the EYRC Session at the ENEA Workshop 2025 | Marseille, France 🇫🇷 Workshop Dates: 3–5 December 2025 More on LinkedIn: @enea-young-researcher-committee 012
Reposted by Giampaolo TrivellinENEA Young Researchers Committee (EYRC) @eyrc.bsky.social · 09/09/2025📢 Call for Abstracts – #ENEAWorkshop2025 🇫🇷 📅 3–5 Dec | Marseille Theme: Changing the Paradigms – Translational Approach in Pituitary Tumors 📌 Deadline: 15 Sept 2025 ✍️ Max 300 words | <41y = YIA eligible 📩 eneacongress@aoscongres.com 🔗 lnkd.in/e4yUiGZ9 011
Reposted by Giampaolo TrivellinVictor Sanchez Gaya @sanchezgaya.bsky.social · 10/07/2025🥳 Happy to share the results of an ongoing work in which we are applying POSTRE (our tool for SV interpretation github.com/vicsanga/Pos...) to better comprehend the cause of X-LAG tumors, a pituitary disorder responsible for an overgrowth condition 🧬. Preprint: www.medrxiv.org/content/10.1... 1/3medrxiv.orgDistinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTREBackground Structural variants (SVs) that disrupt topologically associating domains (TADs) can cause disease by rewiring enhancer-promoter interactions. Duplications involving GPR101 are known to caus... 131
Reposted by Giampaolo TrivellinMartin Franke @martinfranke.bsky.social · 09/07/2025🧵1/3 Our new preprint is out! Proud to have contributed to this collaborative study. We identified the enhancer cluster responsible for GPR101 overexpression in X-linked acrogigantism (X-LAG) - a key step toward understanding this rare pituitary disorder 🧠🧬 🔗 www.medrxiv.org/content/10.1...medrxiv.orgDistinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTREBackground Structural variants (SVs) that disrupt topologically associating domains (TADs) can cause disease by rewiring enhancer-promoter interactions. Duplications involving GPR101 are known to caus... 273
Reposted by Giampaolo TrivellinESE Young Endocrinologists and Scientists (EYES) @ese-eyes.bsky.social · 09/06/2025📣 Thrilled to announce our next speaker for the EYES Annual Meeting in Milan – Prof. Constantine Stratakis! 💡 Register & submit your abstract! ⏳ 🇮🇹 Join us in Milan! @esendocrinology.bsky.social @ksaravinovska.bsky.social 023
Reposted by Giampaolo TrivellinStefan Schoenfelder @stefanschoenfelder.bsky.social · 03/06/2025Delighted & excited to share our latest preprint on non-canonical enhancers in human pluripotent stem cells, the result of a fantastic and fun collaboration with @guenesdoganlab.bsky.social: www.biorxiv.org/content/10.1... 🧵 belowbiorxiv.orgNon-canonical enhancers control gene expression and cell fate in human pluripotent stem cellsEnhancers are key gene regulatory elements that ensure the precise spatiotemporal execution of developmental gene expression programmes. However recent findings indicate that approaches to identify en... 512145
Reposted by Giampaolo TrivellinmedRxivpreprint @medrxivpreprint.bsky.social · 17/05/2025High prevalence of deleterious germline variants in cancer risk genes among subjects with young-onset, sporadic pituitary macroadenomas www.medrxiv.org/content/10.1101/202… 011
Reposted by Giampaolo TrivellinENEA Young Researchers Committee (EYRC) @eyrc.bsky.social · 06/05/2025🚨 New Neuroendo Watch by EYRC – Highlight Alert! 🚨 We spotlight a study revealing how cholesterol metabolism drives dopamine agonist resistance in prolactinomas. 🧪🧠 Full post with takeaways on our LinkedIn page: www.linkedin.com/company/enea-young-researcher-committee 011
Reposted by Giampaolo TrivellinBrilliant Maps @brilliantmaps.bsky.social · 07/04/2025The Oldest University In Every Country In The World brilliantmaps.com/oldest-un... 094
Reposted by Giampaolo TrivellinAltmetric @altmetric.com · 27/03/2025THREAD The numbers are in. @bsky.app research sharing volumes vs X Formerly Twitter In March 2024, on most days, Bluesky hosts more posts linked to research published in 2025 than X. By quite a lot. Release the Kraken... #AcademicSky #HigherEd #Altmetrics 1/11 181211462
Giampaolo Trivellin @gp83.bsky.social · 15/03/2025www.osservatorioterapieavanzate.it/terapie-avan...osservatorioterapieavanzate.itLa storia rara di Sonia e Eric pionieri per forza e per amoreUn’avventura scientifica che ha come ingredienti la minaccia incombente di una malattia fatale, la decisione di reinventarsi entrambi biologi e l’obiettivo di silenziare i prioni. 010
Reposted by Giampaolo TrivellinENEA Young Researchers Committee (EYRC) @eyrc.bsky.social · 10/03/2025🚀 EYRC Neuroendo Watch We highlight a study in Endocrine, offering new insights into MEN5: tinyurl.com/25n94ac3 📌First reported case of pit-gigantism linked to a germline MAX mutation 📌Myelolipoma as a new disease association in MEN5 📌Expansion of the phenotype beyond PPGLs By @gp83.bsky.social 011
Reposted by Giampaolo TrivellinENEA Young Researchers Committee (EYRC) @eyrc.bsky.social · 16/02/2025Welcome to the ENEA Young Researchers Committee (EYRC), a subcommittee of ENEA dedicated to supporting early career scientists in neuroendocrinology. ✨ Our Mission: 🔹 Strengthening ENEA’s visibility 🔹 Representing early career researchers 🔹 Organizing symposia & workshops 🔹 And much more ... 063
Giampaolo Trivellin @gp83.bsky.social · 03/02/2025When your weekend’s pancake turns out to look something like a #zebrafish embryo during the gastrula period 🤣 @zebrafishrock.bsky.social 130
Giampaolo Trivellin @gp83.bsky.social · 30/01/2025www.linkedin.com/posts/activi...linkedin.comGiampaolo Trivellin on LinkedIn: Post doc announcement🔬 🧫 🧬 We are #hiring! 🔬 🧫 🧬 An exciting opportunity awaits at the Humanitas Research Hospital in the Translational Endocrinology and Metabolism Lab! We… 010
Giampaolo Trivellin @gp83.bsky.social · 18/01/2025www.theguardian.com/environment/...theguardian.comHow maverick rewilders are trying to turn back the tide of extinctionThe long read: A handful of radical nature lovers are secretly breeding endangered species and releasing them into the wild. Many are prepared to break the law and risk the fury of the scientific esta... 000
Giampaolo Trivellin @gp83.bsky.social · 18/01/2025Why Is Every Human Being Riddled With Genetic Errors? www.smithsonianmag.com/science-natu...smithsonianmag.comWhy Is Every Human Being Riddled With Genetic Errors?Your body is a collection of cells carrying thousands of genetic mistakes accrued over a lifetime—many harmless, some bad and at least a few that may be good for you 000
Reposted by Giampaolo TrivellinAddgene @addgene.bsky.social · 31/12/2024Did you know 2024 was our 20th anniversary? We're closing it out by sharing a brief history of Addgene, with commentary from our incredible community. Read it below! blog.addgene.org/add...blog.addgene.orgAddgene: The First Twenty YearsTwenty years have gone by fast! Join us to share some highlights of Addgene and our community as we close out our 20th anniversary celebration. 0134
Giampaolo Trivellin @gp83.bsky.social · 26/12/2024www.nytimes.com/2024/12/25/o...nytimes.comOpinion | Pfizer Stopped Us From Getting Ozempic Decades Ago (Gift Article)Researchers identified one key breakthrough for GLP-1 drugs in the 1980s, but Pfizer walked away. 020
Giampaolo Trivellin @gp83.bsky.social · 19/12/2024www.smithsonianmag.com/smart-news/s...smithsonianmag.comScientists Warn of an 'Unprecedented Risk' From Synthetic 'Mirror Life,' Built With a Reverse Version of Natural Proteins and SugarsSo-called mirror cells could rampage through our ecosystems, food supply and immune systems, experts say, potentially without existing barriers to protect against them 020